Medtronic financials
$87.09−2.69%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Apr 24 | FY25 Apr 25 | FY24 Apr 26 | FY23 Apr 28 | FY22 Apr 29 | FY21 Apr 30 | FY20 Apr 24 | FY19 Apr 26 | FY18 Apr 27 | FY17 Apr 28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B | $28.91B | $30.56B | $29.95B | $29.71B |
| Gross profit | $23.64B | $21.91B | $21.15B | $20.51B | $21.54B | $19.63B | $19.49B | $21.40B | $20.89B | $20.42B |
| Gross margin | 65.0% | 65.3% | 65.3% | 65.7% | 68.0% | 65.2% | 67.4% | 70.0% | 69.7% | 68.7% |
| Operating income | $6.47B | $5.96B | $5.14B | $5.49B | $5.75B | $4.48B | $4.79B | $6.27B | $5.94B | $5.38B |
| Net income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B | $4.63B | $3.10B | $4.03B |
| Net margin | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% | 16.6% | 15.2% | 10.4% | 13.6% |
| Diluted EPS | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 | $2.27 | $2.89 |
| EBITDA | $9.79B | $9.40B | $8.17B | $8.56B | $8.62B | $7.60B | $7.88B | $9.29B | $8.68B | $8.90B |
| Operating cash flow | $7.33B | $7.04B | $6.79B | $6.04B | $7.35B | $6.24B | $7.23B | $7.01B | $4.68B | $6.88B |
| Free cash flow | $5.43B | $5.18B | $5.20B | $4.58B | $5.98B | $4.88B | $6.02B | $5.87B | $3.62B | $5.63B |
| Diluted shares | 1,288.1M | 1,289.9M | 1,330.2M | 1,332.8M | 1,351.4M | 1,354.0M | 1,351.1M | 1,357.5M | 1,368.2M | 1,391.4M |
Balance sheet
| Period end | Apr 24 | Apr 25 | Apr 26 | Apr 28 | Apr 29 | Apr 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.95B | $2.22B | $1.28B | $1.54B | $3.71B | $3.59B |
| Short-term investments | $7.27B | $6.75B | $6.72B | $6.42B | $6.86B | $7.22B |
| Total debt | $27.96B | $28.52B | $25.02B | $24.36B | $24.11B | $26.39B |
| Total assets | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B | $93.08B |
| Total liabilities | $42.96B | $43.42B | $39.56B | $39.28B | $38.26B | $41.48B |
| Shareholders' equity | $50.07B | $48.26B | $50.42B | $51.66B | $52.72B | $51.60B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology